Champix, Singapore

Champix, Singapore @beautysingapore_com: Quit/stop smoking with the medication Champix®. Smoking cessation clinic, Singapore. Private and confidential services. Definitions, references, and latest news.

Description

Quit smoking with the medication Champix®. Revolutionary new way to stop smoking at our smoking cessation clinic. Get away from the harmful effects of smoking, without feeling the effects of withdrawal!

Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:

SHIM CLINIC 168 Bedok South Avenue 3 #01-473 Singapore 460168 Tel: (+65) 6446 7446 Fax: (+65) 6449 7446 24hr Answering Tel: (+65) 6333 5550 Web: Champix, Singapore

Opening Hours Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm Saturday & Sunday: 7 pm to 11 pm Public Holidays: Closed Last registration: half hour before closing time. Walk-in clinic. Appointments not required. Bring NRIC, Work Pass or Passport for registration.

References

• Champix - Wikipedia, the free encyclopedia
• Champix: Definition from Answers.com

Table of Contents
Fri, 14 Jun 2013 16:55:24 +0100 | The Brown University Psychopharmacology Update
Abstract

Adverse drug reactions reported by consumers for nervous system medications in Europe 2007 to 2011
Thu, 13 Jun 2013 04:00:00 +0100 | BMC Clinical Pharmacology
Conclusions:

Who receives prescriptions for smoking cessation medications? An association rule mining analysis using a large primary care database
Tue, 11 Jun 2013 04:00:00 +0100 | Tobacco Control
Conclusions

Table of Contents
Mon, 10 Jun 2013 04:00:00 +0100 | Alcoholism and Drug Abuse Weekly
Abstract

Varenicline for alcohol dependence? CV events and suicide concerns linger
Fri, 07 Jun 2013 18:45:00 +0100 | theHeart.org
New research suggests the smoking cessation drug varenicline may aid in the treatment of alcohol dependence, but reaction to the study suggests this approach may face some hurdles. (Source: theHeart.org)

Drug May Aid in Alcohol Dependence, but Safety Concerns LingerDrug May Aid in Alcohol Dependence, but Safety Concerns Linger
Thu, 06 Jun 2013 19:37:37 +0100 | Medscape Today Headlines
Varenicline may aid in the treatment of alcohol dependence, preliminary research shows. However, concerns about an increased risk for suicidal thoughts and cardiovascular events linger. Medscape Medical News (Source: Medscape Today Headlines)

The effects of varenicline on stress-induced and cue-induced craving for cigarettes
Thu, 06 Jun 2013 06:17:39 +0100 | Drug and Alcohol Dependence
Abstract: Background: Varenicline is a partial agonist of the α4β2 nicotinic acetylcholine receptor approved by the FDA for the treatment of nicotine dependence. While the clinical efficacy of varenicline for smoking cessation is well-supported, its biobehavioral mechanisms of action remain poorly understood. This randomized, crossover, placebo-controlled, human laboratory study combines guided imagery stress exposure with in vivo presentation of cigarette cues to test the effects of varenicline on stress-induced and cue-induced craving for cigarettes.Method: A total of 40 (13 females) daily smokers (≥10 cigarettes per day) completed a guided imagery exposure (stress and neutral) followed by the presentation of cigarette cues at the target dose of varenicline (1mg twice per day) and on...

Chantix May Treat Alcohol Dependence and Abuse
Wed, 05 Jun 2013 07:00:00 +0100 | eMedicineHealth.com
Anti-smoking Medication Shows Promise for Treating Alcohol Dependence (Source: eMedicineHealth.com)

Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomized controlled trial
Wed, 29 May 2013 04:00:00 +0100 | BMC Medicine
In a randomized trial, participants seeking to quit smoking over 12 weeks did not benefit from adding nicotine patch to varenicline, suggesting that although further trials are required, there is no benefit in taking both treatments. (Source: BMC Medicine)

Divergent Functional Effects of Sazetidine-A and Varenicline During Nicotine Withdrawal
Wed, 29 May 2013 04:00:00 +0100 | Neuropsychopharmacology
Authors: Jill R Turner, Derek S Wilkinson, Rachel LF Poole, Thomas J Gould, Gregory C Carlson